These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19322702)

  • 1. Survivin multifaceted activity in head and neck carcinoma: current evidence and future therapeutic challenges.
    Marioni G; D'Alessandro E; Bertolin A; Staffieri A
    Acta Otolaryngol; 2010; 130(1):4-9. PubMed ID: 19322702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
    Su L; Wang Y; Xiao M; Lin Y; Yu L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High nuclear expression of the apoptosis inhibitor protein survivin is associated with disease recurrence and poor prognosis in laryngeal basaloid squamous cell carcinoma.
    Marioni G; Ottaviano G; Marchese-Ragona R; Giacomelli L; Bertolin A; Zanon D; Marino F; Staffieri A
    Acta Otolaryngol; 2006 Feb; 126(2):197-203. PubMed ID: 16428200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of Cisplatin sensitivity in squamous cell carcinoma of the head and neck transfected with a survivin antisense gene.
    Kojima H; Iida M; Yaguchi Y; Suzuki R; Hayashi N; Moriyama H; Manome Y
    Arch Otolaryngol Head Neck Surg; 2006 Jun; 132(6):682-5. PubMed ID: 16785416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth inhibition and chemo-radiosensitization of head and neck squamous cell carcinoma (HNSCC) by survivin-siRNA lentivirus.
    Khan Z; Khan AA; Prasad GB; Khan N; Tiwari RP; Bisen PS
    Radiother Oncol; 2016 Feb; 118(2):359-68. PubMed ID: 26747757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the apoptosis inhibitor protein Survivin in primary laryngeal carcinoma and cervical lymph node metastasis.
    Marioni G; Bertolin A; Giacomelli L; Marchese-Ragona R; Savastano M; Calgaro N; Marino F; De Filippis C; Staffieri A
    Anticancer Res; 2006; 26(5B):3813-7. PubMed ID: 17094406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense-mediated downregulation of anti-apoptotic proteins induces apoptosis and sensitizes head and neck squamous cell carcinoma cells to chemotherapy.
    Sharma H; Sen S; Lo Muzio L; Mariggiò A; Singh N
    Cancer Biol Ther; 2005 Jul; 4(7):720-7. PubMed ID: 15917659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined evaluation of expression of telomerase, survivin, and anti-apoptotic Bcl-2 family members in relation to loss of differentiation and apoptosis in human head and neck cancers.
    Sharma H; Sen S; Mathur M; Bahadur S; Singh N
    Head Neck; 2004 Aug; 26(8):733-40. PubMed ID: 15287041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear Survivin expression is correlated with malignant behaviors of head and neck cancer together with Aurora-B.
    Qi G; Kudo Y; Ando T; Tsunematsu T; Shimizu N; Siriwardena SB; Yoshida M; Keikhaee MR; Ogawa I; Takata T
    Oral Oncol; 2010 Apr; 46(4):263-70. PubMed ID: 20138567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of survivin expression suppresses the growth of aggressive non-Hodgkin's lymphoma.
    Ansell SM; Arendt BK; Grote DM; Jelinek DF; Novak AJ; Wellik LE; Remstein ED; Bennett CF; Fielding A
    Leukemia; 2004 Mar; 18(3):616-23. PubMed ID: 14749704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
    Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
    Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survivin is a downstream target and effector of sulindac-sensitive oncogenic Stat3 signalling in head and neck cancer.
    Scheper MA; Nikitakis NG; Sauk JJ
    Int J Oral Maxillofac Surg; 2007 Jul; 36(7):632-9. PubMed ID: 17566705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor survivin is downregulated by the antisense oligonucleotide LY2181308: a proof-of-concept, first-in-human dose study.
    Talbot DC; Ranson M; Davies J; Lahn M; Callies S; André V; Kadam S; Burgess M; Slapak C; Olsen AL; McHugh PJ; de Bono JS; Matthews J; Saleem A; Price P
    Clin Cancer Res; 2010 Dec; 16(24):6150-8. PubMed ID: 21041181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of the inhibitor of apoptosis protein survivin sensitizes Bcr-abl-positive cells to STI571-induced apoptosis.
    Wang Z; Sampath J; Fukuda S; Pelus LM
    Cancer Res; 2005 Sep; 65(18):8224-32. PubMed ID: 16166298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of survivin for radiation therapy. Prognostic and predictive factor and therapeutic target.
    Capalbo G; Rödel C; Stauber RH; Knauer SK; Bache M; Kappler M; Rödel F
    Strahlenther Onkol; 2007 Nov; 183(11):593-9. PubMed ID: 17960333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of apoptosis and sensitization of head and neck squamous carcinoma cells to cisplatin by targeting survivin gene expression.
    Khan Z; Tiwari RP; Khan N; Prasad GB; Bisen PS
    Curr Gene Ther; 2012 Dec; 12(6):444-53. PubMed ID: 22974420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxaliplatin-mediated inhibition of survivin increases sensitivity of head and neck squamous cell carcinoma cell lines to paclitaxel.
    Khan Z; Khan N; Varma AK; Tiwari RP; Mouhamad S; Prasad GB; Bisen P
    Curr Cancer Drug Targets; 2010 Nov; 10(7):660-9. PubMed ID: 20578991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MASPIN tumour-suppressing activity in head and neck squamous cell carcinoma: emerging evidence and therapeutic perspectives.
    Marioni G; Staffieri C; Staffieri A; De Filippis C; Blandamura S
    Acta Otolaryngol; 2009 May; 129(5):476-80. PubMed ID: 18615330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell growth inhibition and down-regulation of survivin by silibinin in a laryngeal squamous cell carcinoma cell line.
    Bang CI; Paik SY; Sun DI; Joo YH; Kim MS
    Ann Otol Rhinol Laryngol; 2008 Oct; 117(10):781-5. PubMed ID: 18998509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.